Holdings
Spruce Street Capital LP
As of Sep 30, 2026, Spruce Street Capital LP reported 33 positions worth US$454M. Largest: Relay Therapeutics, Inc., LB Pharmaceuticals Inc and Alto Neuroscience, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Relay Therapeutics, Inc. | 2.98M | US$53.9M | no change | Sep 30, 2026 |
| LB Pharmaceuticals Inc | 1.4M | US$53.9M | +28,620 | Sep 30, 2026 |
| Alto Neuroscience, Inc. | 1.68M | US$42.8M | +324K | Sep 30, 2026 |
| Dianthus Therapeutics, Inc. | 355K | US$31.2M | no change | Sep 30, 2026 |
| Savara, Inc. | 5.38M | US$27.8M | +1.93M | Sep 30, 2026 |
| Zai Lab Ltd. | 1.04M | US$27.5M | +763K | Sep 30, 2026 |
| Relmada Therapeutics, Inc. | 6.91M | US$26.1M | +521K | Sep 30, 2026 |
| Vaxcyte, Inc. | 306K | US$17.4M | no change | Sep 30, 2026 |
| Obsidian Therapeutics, Inc. | 1.25M | US$17.2M | new | Sep 30, 2026 |
| Enliven Therapeutics, Inc. | 329K | US$15.1M | no change | Sep 30, 2026 |